Journal Articles

A multi-centred retrospective analysis of 336 clinical evaluations of the Medi Derma Total Barrier Protection (TBP™) Product Range

Share this article

A multi-centred retrospective analysis of 336 clinical evaluations of the Medi Derma Total Barrier Protection (TBP™) Product Range

Alexandra Freitas, Dale Copson
8 March 2021

Over the last decade, modern skin barrier products have steadily replaced the use of traditional barrier products to maintain the skin integrity of vulnerable patients. These cream, film and ointment preparations are designed to protect skin from the effects of mechanical or chemical injury. They are predominantly used in the prevention and management of moisture-associated skin damage (MASD), an umbrella term used to define the various causes of damage associated with prolonged, or continuous exposure of the skin to moisture (Young, 2017). They offer protection from moisture due to incontinence, perspiration or wound/stoma drainage, forming a transparent, waterproof protective coating on the skin, and can be applied to intact or broken skin. They may be formulated from a variety of substances including acrylates, polymers, and silicone (NHS Clinical Evaluation Team, 2017).

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.